Here’s their press release WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance. Invistics will join the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions. “Invistics’ advanced technology solution fits […]

Leave a Reply

Your email address will not be published. Required fields are marked *